Aurora Cannabis Stock Forecast, Price & News

15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Aurora Cannabis in the last twelve months. There are currently 6 sell ratings and 9 hold ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" Aurora Cannabis stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ACB, but not buy additional shares or sell existing shares.
View analyst ratings for Aurora Cannabis or view top-rated stocks.

Wall Street analysts have given Aurora Cannabis a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Aurora Cannabis wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Aurora Cannabis saw a decrease in short interest in the month of February. As of February 12th, there was short interest totaling 19,200,000 shares, a decrease of 25.8% from the January 28th total of 25,890,000 shares. Based on an average daily volume of 32,600,000 shares, the days-to-cover ratio is presently 0.6 days. Approximately 9.8% of the shares of the stock are sold short.
View Aurora Cannabis' Short Interest.

Aurora Cannabis is scheduled to release its next quarterly earnings announcement on Thursday, May 13th 2021.
View our earnings forecast for Aurora Cannabis.

Aurora Cannabis Inc. (NYSE:ACB) announced its quarterly earnings results on Thursday, February, 11th. The company reported ($0.28) EPS for the quarter, missing the Zacks' consensus estimate of ($0.19) by $0.09. The company earned $51.93 million during the quarter, compared to analysts' expectations of $54.66 million. Aurora Cannabis had a negative net margin of 1,238.94% and a negative trailing twelve-month return on equity of 16.32%.
View Aurora Cannabis' earnings history.

Aurora Cannabis' stock was trading at $10.3044 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, ACB shares have decreased by 5.9% and is now trading at $9.70.
View which stocks have been most impacted by COVID-19.

Aurora Cannabis shares reverse split on Monday, May 11th 2020. The 1-12 reverse split was announced on Friday, May 8th 2020. The number of shares owned by shareholders was adjusted after the closing bell on Friday, May 8th 2020. An investor that had 100 shares of Aurora Cannabis stock prior to the reverse split would have 8 shares after the split.

15 Wall Street analysts have issued 1-year target prices for Aurora Cannabis' shares. Their forecasts range from $3.60 to $18.50. On average, they anticipate Aurora Cannabis' share price to reach $11.24 in the next twelve months. This suggests a possible upside of 15.9% from the stock's current price.
View analysts' price targets for Aurora Cannabis or view top-rated stocks among Wall Street analysts.

Some companies that are related to Aurora Cannabis include STADA Arzneimittel Aktiengesellschaft (STDAF), Aphria (APHA), Tilray (TLRY), Cronos Group (CRON), Sundial Growers (SNDL), USANA Health Sciences (USNA), HEXO (HEXO), ChromaDex (CDXC), Canopy Rivers (RIV), Charlie's (CHUC), MediWound (MDWD), Natural Alternatives International (NAII), Nutra Pharma (NPHC), Glucose Health (GLUC) and Happiness Biotech Group (HAPP).
View all of ACB's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Aurora Cannabis investors own include (CGC), Cronos Group (CRON), (APHA), NVIDIA (NVDA), (HEXO), Tilray (TLRY), Alibaba Group (BABA), Advanced Micro Devices (AMD), General Electric (GE) and Micron Technology (MU).

Aurora Cannabis trades on the New York Stock Exchange (NYSE) under the ticker symbol "ACB."

Aurora Cannabis' stock is owned by many different retail and institutional investors. Top institutional investors include ETF Managers Group LLC (4.79%), Public Sector Pension Investment Board (0.36%), Swiss National Bank (0.29%), CIBC Asset Management Inc (0.22%), BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp (0.20%) and Seven Eight Capital LP (0.15%).

ACB stock was sold by a variety of institutional investors in the last quarter, including JPMorgan Chase & Co., Seven Eight Capital LP, Hsbc Holdings PLC, Toronto Dominion Bank, and AdvisorNet Financial Inc.

ACB stock was purchased by a variety of institutional investors in the last quarter, including ETF Managers Group LLC, CIBC Asset Management Inc, BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp, Public Sector Pension Investment Board, Swiss National Bank, Credit Suisse AG, The Manufacturers Life Insurance Company , and Vontobel Holding Ltd..

Shares of ACB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of ACB stock can currently be purchased for approximately $9.70.

Aurora Cannabis has a market capitalization of $1.92 billion and generates $207.89 million in revenue each year. The company earns $-2,468,190,000.00 in net income (profit) each year or ($2.86) on an earnings per share basis.

Aurora Cannabis employs 2,731 workers across the globe.

The official website for Aurora Cannabis is auroramj.com.

Aurora Cannabis is headquartered at 10355 JASPER AVENUE SUITE 500, EDMONTON A0, T5J 1Y6.

Aurora Cannabis' mailing address is 10355 JASPER AVENUE SUITE 500, EDMONTON A0, T5J 1Y6. The company can be reached via phone at 1-855-279-4652 or via email at [email protected]